Nike To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Mizuho cut Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) price target from $140 to $132. Mizuho analyst Graig…